Copyright 201o Brady Barrows
Non Prescription (Over the Counter [OTC])
How much money is being spent on rosacea? According to a NY Times article, “Sales of anti-redness facial care products grew by 35 percent from 2002 to 2007, an increase of $300 million, according to Kline’s 2007 global cosmetics and toiletries report. That figure, Ms. Wang said, doesn’t include products designed for sensitive skin or uneven complexions, which also purport to quell rosacea.”
This gives you an idea of the market for anti-redness OTC products.
Prescription Treatments
A Market Watch report says “the current size of the U.S. rosacea products market is around $500 million.”
Note this 2004 Business Wire report stated:
“With 85% of people worldwide suffering from acne at some point in their lives, leading to more than 103 million affected by acne and another 45 million by rosacea, the global market for prescription dermatological therapeutics continues to be substantial. Current drugs include a variety of topical and systemic medications such as antibiotics, anti-infectives, anti-inflammatory, hormone therapies, keratolytics, and retinoids–many of which are indicated for both diseases.
The worldwide acne and rosacea therapeutics market is estimated at over $2.16B in 2004 and is expected to grow at a compound annual rate of 1.4% to reach more than $2.31B worldwide by 2009. Although market growth is stabilizing, there is still a pressing demand for new products since most current therapies are associated with adverse side effects including skin irritation, depression, and birth defects.”
There are actual figures provided about this from Mindbranch with their report The Dermatology Market Outlook to 2011 which covers the ’5 Major dermatological indications,’ rosacea being one of these and says about this report:
“The Dermatology Market Outlook to 2011 provides detailed analysis on 5 indications within the dermatology market, identifying high growth brands, future market leaders and key drug classes. The in-depth 6-year epidemiology and product sales forecasts in this report will enable you to plan effectively, evaluate changes in the competitive positions of leading companies and accurately benchmark your position.”
If you can get this report it would be a great benefit to know what it says the market share is for rosacea. But I can’t afford to buy this report but if you can let us know what you find out? If you live in the UK you can buy this report by clicking here. pharmalicensing.com also sells this report. The abstract of this report says the following:
“Forecast sales of the acne market are estimated at $2.7bn in 2011.”
There is no forecast figures for rosacea but it may be similar. And remember, these are prescription drugs only.
Another outlook report for 2013.
Sources:
“The revenue of dermatological market in 2006 was $16bn”
The World Dermatological Market Analysis & Forecasts 2007-2022
“Research and Markets: Acne & Rosacea Therapeutics: Ten Emerging Acne and Rosacea Therapies in Phase and Clinical Development Expected to launch by 2009″. Business Wire
